TCD-51073

N/A

Report date: 2022/11/27 23:59:05

Base Information

Drug NameTCD-51073

Drug Alias NameTCD-51073

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Skeletal myoblast therapyCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTerumo

China Registration ClassN/A

Develop Information

Active CompaniesTerumo

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A